Yingjun Yan
Vanderbilt University(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, HER2/EGFR in Cancer Research, Cancer therapeutics and mechanisms, Lung Cancer Research Studies, Cancer Mechanisms and Therapy
Most-Cited Works
- → Rationale for co-targeting IGF-1R and ALK in ALK fusion–positive lung cancer(2014)266 cited
- → SFK/FAK Signaling Attenuates Osimertinib Efficacy in Both Drug-Sensitive and Drug-Resistant Models of EGFR-Mutant Lung Cancer(2017)141 cited
- → EGFR Fusions as Novel Therapeutic Targets in Lung Cancer(2016)140 cited
- → Longitudinal Cell-Free DNA Analysis in Patients with Small Cell Lung Cancer Reveals Dynamic Insights into Treatment Efficacy and Disease Relapse(2017)135 cited
- → Improved Identification of Yeast Species Directly from Positive Blood Culture Media by Combining Sepsityper Specimen Processing and Microflex Analysis with the Matrix-Assisted Laser Desorption Ionization Biotyper System(2011)111 cited
- → On-target Resistance to the Mutant-Selective EGFR Inhibitor Osimertinib Can Develop in an Allele-Specific Manner Dependent on the Original EGFR-Activating Mutation(2019)107 cited
- → Large fragment of the probasin promoter targets high levels of transgene expression to the prostate of transgenic mice(1997)90 cited
- → Structure–function analysis of oncogenic EGFR Kinase Domain Duplication reveals insights into activation and a potential approach for therapeutic targeting(2021)68 cited
- → Clinical Analyses of Clustered Microcalcifications after Autologous Fat Injection for Breast Augmentation(2010)52 cited
- → Beyond Programmed Death-Ligand 1: B7-H6 Emerges as a Potential Immunotherapy Target in SCLC(2021)31 cited